risankizumab
abbvie
['abbvie']
at #eadv2022, we re presenting new data in #psoriaticarthritis. learn more: 
AbbVie's global handle featuring biopharmaceutical news & updates managed by our corp digital team. Review our guidelines: https://t.co/oWTsp1VCTN